• 中国科学论文统计源期刊
  • 中国科技核心期刊
  • 美国化学文摘(CA)来源期刊
  • 日本科学技术振兴机构数据库(JST)

临床输血与检验 ›› 2022, Vol. 24 ›› Issue (5): 588-590.DOI: 10.3969/j.issn.1671-2587.2022.05.007

• 临床输血 • 上一篇    下一篇

自身抗体阳性致配血不相合红细胞输注疗效分析

宋倩, 马怡然   

  1. 110001 中国医科大学附属第一医院输血科
  • 收稿日期:2022-06-29 出版日期:2022-10-20 发布日期:2022-10-31
  • 通讯作者: 马怡然,女,副教授,博士,主要从事临床输血研究,(E-mail)13898807150@163.com。
  • 作者简介:宋倩(1988-),女,检验技师,学士,主要从事临床输血研究,(E-mail)871809702@qq.com。

Therapeutic Efficacy of Red Blood Cell Transfusions in Patients with Positive Crossmatching Test Caused by Autoantibodies

SONG Qian, MA Yi-ran   

  1. The First Hospital of China Medical University, Liaoning 110001
  • Received:2022-06-29 Online:2022-10-20 Published:2022-10-31

摘要: 目的 分析自身抗体阳性导致输注不相合红细胞患者的输血疗效,为临床安全、合理输血提供依据。方法 对本院2021年5月~2022年6月35例自身抗体阳性致不相合输血患者的病历、输血资料进行统计和分析。结果 35例患者共60次输血申请,4次拒输,56次不相合输血中输血有效52次(92.9%);输血后总胆红素(total bilirubin, TBIL)与间接胆红素(indirect bilirubin, IBIL)无明显升高;输注滤白红细胞悬液与滤白洗涤红细胞输血疗效无显著性差异(P>0.05);所有输血患者未发生输血反应。结论 自身抗体阳性导致配血不相合,选择主侧凝集强度不强于自身凝集强度的ABO和Rh同型的红细胞,输注安全有效。输血科应加强与医患沟通,改善医疗质量。同时应加强避免自身抗体影响输血前试验的研究。

关键词: 输血, 自身抗体, 自身免疫性溶血性贫血, 交叉配血

Abstract: Objective To analyze the efficacy of transfusion in patients with mismatched red blood cells caused by auto-antibodies, thus providing evidence for clinical safety and rational transfusion. Methods The clinical records and blood transfusion data of 35 patients with incompatible transfusion due to positive autoantibodies from May 2021 to June 2022 in our hospital were collected and statistically analyzed. Results A total of 60 transfusion applications had been made by 35 patients, 4 of which were rejected. Among 56 incompatible transfusions, 52 (92.9%) were found to be effective. There was no significant increase in TBIL after transfusion. No significant difference was observed in efficacy between transfusion of washed erythrocytes and that of non-washed erythrocytes (P>0.05). All patients had no transfusion reactions. Conclusion In case positive autoantibodies lead to blood mismatch, transfusion of ABO and Rh homologous red blood cells is safe and effective, whose primary agglutination strength is not higher than that of self-agglutination. It is advisable for blood transfusion departments to enhance doctor-patient communication to avert medical accidents; simultaneously, efforts should be made for more studies to prevent autoantibodies from affecting pre-transfusion tests.

Key words: Blood transfusion, Autoantibodies, Autoimmune hemolytic anemia (AIHA), Cross matching

中图分类号: